Jane Street’s GenMark Diagnostics, Inc GNMK Stock Holding History

Jane Street’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,610	Closed	-$1.38M	–	10853
2021 Q1	$1.38M	Buy	57,610 +44,719	+347%	+$831K	﹤0.01%	4804
2020 Q4	$189K	Sell	12,891 -40,351	-76%	-$535K	﹤0.01%	6979
2020 Q3	$756K	Buy	53,242 +33,442	+169%	+$511K	﹤0.01%	4533
2020 Q2	$291K	Buy	+19,800	New	+$201K	﹤0.01%	5889
2014 Q3	–	Sell	-48,824	Closed	-$661K	–	3249
2014 Q2	$661K	Buy	+48,824	New	+$509K	0.01%	1202
2014 Q1	–	Sell	-12,579	Closed	-$167K	–	3194
2013 Q4	$167K	Buy	+12,579	New	+$153K	﹤0.01%	2082

Jane Street's GNMK Position: Q2 2021 in Review

Jane Street sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 57,610 shares — an estimated $1.38M sold.

Jane Street first reported a position in GNMK in Q4 2013 and held it in 6 quarters. The position peaked at $1.38M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Jane Street reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Jane Street sold 57,610 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.38M.
Jane Street first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 6 quarters.
Jane Street's GenMark Diagnostics, Inc position peaked at $1.38M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.